Inventor · disambiguated record
Timothy Mckinsey
Also filed as: MCKINSEY TIMOTHY · MCKINSEY TIMOTHY A
7 granted patents·9 pending applications·171 citations·filing 2000–2020
86Inventor score
Files withUNIV TEXAS5UNIV COLORADO REGENTS4LONG CARLIN2MCKINSEY TIMOTHY A2MYOGEN INC AND BOARD OF REGENT1
Top patents by PatentIndex Score
16 records- 0195US6706686B2Inhibition of histone deacetylase as a treatment for cardiac hypertrophyUNIV COLORADO·Filed 2002·Granted Mar 16, 2004·92 cites·50 claims
- 0292US6946441B2Inhibition of histone deacetylase as a treatment for cardiac hypertrophyUNIV TEXAS·Filed 2004·Granted Sep 20, 2005·45 cites·10 claims
- 0385US9885018B1High efficiency reprogramming of fibroblasts into cardiomyocytesUNIV COLORADO REGENTS·Filed 2016·Granted Feb 6, 2018·5 cites·13 claims
- 0483US6632628B1Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expressionUNIV TEXAS·Filed 2000·Granted Oct 14, 2003·24 cites·21 claims
- 0575US7863414B2Methods of treatment and uses for CaMKII and its interaction with HDACs and calpainUNIV TEXAS·Filed 2006·Granted Jan 4, 2011·4 cites·9 claims
- 0666US2009087412A1Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expressionOLSON ERIC N·Filed 2008·Application pending·0 cites
- 0761US7420100B2Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expressionUNIV TEXAS·Filed 2003·Granted Sep 2, 2008·1 cites·5 claims
- 0858US10519423B1High efficiency reprogramming of fibroblasts into cardiomyocytesUNIV COLORADO REGENTS·Filed 2017·Granted Dec 31, 2019·0 cites·35 claims
- 0954US2006069014A1Inhibition of histone deacetylase as a treatment for cardiac hypertrophyLONG CARLIN·Filed 2005·Application pending·0 cites
- 1054US2006025333A1Inhibition of histone deacetylase as a treatment for cardiac hypertrophyLONG CARLIN·Filed 2005·Application pending·0 cites
- 1153US2020362314A1Methods to produce adult-like cardiomyocytes derived from induced pluripotent stem cells for drug discoveryUNIV COLORADO REGENTS·Filed 2020·Application pending·0 cites
- 1251US2005112128A1Inhibition of protein kinase c-mu (PKD) as a treatment for cardiac hypertrophy and heart failureMYOGEN INC AND BOARD OF REGENT·Filed 2004·Application pending·0 cites
- 1348US2005288215A1Inhibition of nuclear export as a treatment for cardiac hypertrophy and heart failureMCKINSEY TIMOTHY A·Filed 2005·Application pending·0 cites
- 1443US2005283841A1Inhibition of protein kinase C-related kinase (PRK) as a treatment for cardiac hypertrophy and heart failureMCKINSEY TIMOTHY A·Filed 2005·Application pending·0 cites
- 1541US2019119364A1Compounds and compositions useful for treating metabolic syndrome, and methods using sameUNIV COLORADO REGENTS·Filed 2017·Application pending·0 cites
- 1639US2011171196A1Methods of treatment and uses for camkii and its interaction with hdacs and calpainUNIV TEXAS·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →